Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms.
New AI score enhances monitoring of myelodysplastic neoplasms
- Post author:admin
- Post published:
- Post category:uncategorized